Asia Pacific Blood Glucose Monitoring Market  Research Report –Forecast till 2027

Asia Pacific Blood Glucose Monitoring Market Information: By Product Type (Invasive Glucose Monitoring, CGM, Flash Glucose Monitoring), Application (Type 1 Diabetes, Type 2 Diabetes), & End User (Diagnostic Centers, Hospitals, Clinics) - Forecast till 2027

ID: MRFR/MED/0189-HCR | February 2021 | Region: Global | 115 pages         

Asia Pacific Blood Glucose Monitoring Market

Asia Pacific blood glucose monitoring devices market is expected to grow USD 8.6 billion at a CAGR of 10% over the forcast period

Segmentation

By Product Type Invasive Glucose Monitoring CGM Flash Glucose Monitoring
Application Type 1 Diabetes Type 2 Diabetes
End User Diagnostic Centers Hospitals Clinics

Key Players

  • Abbott Laboratories
  • Arkay
  • Inc.
  • Bayer Healthcare AG
  • F. Hoffmann-La Roche
  • Goldsite Diagnostics Inc.
  • GlySure Ltd
  • Sphere Medical
  • Dexcom
  • LifeScan

Drivers

  • increasing prevalence of diabetes
  • developing technology for monitoring and diagnosis of diabetes
  • early detection of diabetes
  • increasing demand for continuous glucose monitoring devices
Speak to Analyst Request a Free Sample

Market Scenario


Blood glucose monitoring is the process of testing the glucose level in the blood. It helps to identify the blood glucose level within the specified target range. Thus, it helps to understand the food intake, exercise, insulin, and blood glucose level. The blood glucose monitoring devices provide useful information to manage diabetes. It helps to track the progress of treatment goal as well as monitor the effect of diabetes meditation on blood sugar level and understand the effect of illness and stress on the blood sugar level.


Various blood glucose monitoring devices are available in the market, which is referred as blood glucose meter. These device help to track the blood glucose level at home, clinics, hospitals, etc. Furthermore, they are designed to apply to the different type of diabetes.


The blood glucose monitoring devices market growth is majorly attributed to the increasing prevalence of diabetes,  developing technology for monitoring and diagnosis of diabetes, early detection of diabetes, and increasing demand for continuous glucose monitoring devices.


The Asia Pacific blood glucose monitoring devices market is expected to grow at a CAGR of 10% over the review period. China and India are potential market players owing to the largest diabetes patient population.


According to the Diabetes prevalence figures suggested by the Australian Bureau of Statistics, more than 5.1% of the Australian population diagnosed with diabetes in 2016.


However, as per the Centers for Disease Control and Prevention (CDC), the risk of transmitting hepatitis B virus (HBV) and other infection during assisted blood glucose monitoring and insulin administration is more.


Intended Audience



  • Diagnostic centers

  • Hospitals

  • Homecare Diagnostics

  • Clinics 


Figure: Asia Pacific Blood Glucose Monitoring Market, By Application Market Share, 2016 (%) Asia <a href='https://www.marketresearchfuture.com/reports/asia-pacific-blood-glucose-test-strip-packaging-market-626'>Pacific Blood</a> Glucose Monitoring Market Sources: Annual reports, Press release, White paper, Company presentation


 Segmentations The Asia Pacific blood glucose monitoring devices market is segmented on the basis of product type, application, and end user


On the basis of the product type, it is segmented into invasive glucose monitoring devices, continuous glucose monitoring devices (CGM), flash glucose monitoring devices, and others.


On the basis of the application, it is segmented into type 1 diabetes, type 2 diabetes, and others.


On the basis of the end user, it is segmented into diagnostic centers, hospitals, clinics, research centers, and home care diagnostics.


Research Methodology


Asia <a href='https://www.marketresearchfuture.com/reports/asia-pacific-blood-glucose-test-strip-packaging-market-626'>Pacific Blood</a> Glucose Monitoring Market-


Sources: Annual reports, Press release, White paper, and Company presentation


Regional Analysis China dominates the Asia Pacific blood glucose monitoring devices market owing to well-developed technology, increasing patient population with diabetes, high health care spending, and increasing government support for research & development. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the market in this region.


India holds the second position in the Asia Pacific blood glucose market owing to the government support for research & development and availability of funds for research. This is expected to continue driving the Indian market over the forecasted period. Moreover, countries like Japan, Australia, and the Republic of Korea are showing a considerable growth in the blood glucose monitoring market.


Asia Pacific is the fastest growing blood glucose monitoring market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing demand for new treatment methods in countries like India and South Korea is likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare is projected to lead the demand for advanced equipment, which, in turn, may increase the market demand for the blood glucose monitoring devices in the region.


Key Players Some of key the players in the market are Abbott Laboratories, Arkay, Inc., Bayer Healthcare AG, F. Hoffmann-La Roche, Goldsite Diagnostics Inc., GlySure Ltd, Sphere Medical, Dexcom, Inc., and LifeScan. 


 



Speak to Analyst Ask for Customization